No systematic attempts have been made to estimate the global and regional prevalence
of amphetamine, cannabis, cocaine, and opioid dependence, and quantify their burden.
We aimed to assess the prevalence and burden of drug dependence, as measured in years
of life lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted
life years (DALYs).
We conducted systematic reviews of the epidemiology of drug dependence, and analysed
results with Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD
2010) Bayesian meta-regression technique (DisMod-MR) to estimate population-level
prevalence of dependence and use. GBD 2010 calculated new disability weights by use
of representative community surveys and an internet-based survey. We combined estimates
of dependence with disability weights to calculate prevalent YLDs, YLLs, and DALYs,
and estimated YLDs, YLLs, and DALYs attributable to drug use as a risk factor for
other health outcomes.
Illicit drug dependence directly accounted for 20·0 million DALYs (95% UI 15·3-25·4
million) in 2010, accounting for 0·8% (0·6-1·0) of global all-cause DALYs. Worldwide,
more people were dependent on opioids and amphetamines than other drugs. Opioid dependence
was the largest contributor to the direct burden of DALYs (9·2 million, 95% UI 7·1-11·4).
The proportion of all-cause DALYs attributed to drug dependence was 20 times higher
in some regions than others, with an increased proportion of burden in countries with
the highest incomes. Injecting drug use as a risk factor for HIV accounted for 2·1
million DALYs (95% UI 1·1-3·6 million) and as a risk factor for hepatitis C accounted
for 502,000 DALYs (286,000-891,000). Suicide as a risk of amphetamine dependence accounted
for 854,000 DALYs (291,000-1,791,000), as a risk of opioid dependence for 671,000
DALYs (329,000-1,730,000), and as a risk of cocaine dependence for 324,000 DALYs (109,000-682,000).
Countries with the highest rate of burden (>650 DALYs per 100,000 population) included
the USA, UK, Russia, and Australia.
Illicit drug use is an important contributor to the global burden of disease. Efficient
strategies to reduce disease burden of opioid dependence and injecting drug use, such
as delivery of opioid substitution treatment and needle and syringe programmes, are
needed to reduce this burden at a population scale.
Australian National Health and Medical Research Council, Australian Government Department
of Health and Ageing, Bill & Melinda Gates Foundation.
Copyright © 2013 Elsevier Ltd. All rights reserved.